Human papillomavirus genotypes distribution in cervical samples from Uruguayan women

Journal of Medical Virology

Volumn 85, Issue 5, 2013, Pages 845-851

  Ramas, Viviana ^a   Mirazo, Santiago ^a   Bonilla, Sylvia ^b   Mendoza, Laura ^c   Lago, Olga ^b   Basiletti, Jorge ^d   González, Joaquin ^d   Picconi, Maria Alejandra ^d   Arbiza, Juan ^a  

^a UNIVERSIDAD DE LA REPÚBLICA   (Uruguay)

^b Cytology Laboratory   (Uruguay)

^c University of Asunción   (Paraguay)

^d INSTITUTE FOR CLINICAL EFFECTIVENESS AND HEALTH POLICY   (Argentina)

Author keywords

Cross sectional study; HPV prevalence; Squamous intraepithelial lesion

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CROSS-SECTIONAL STUDY; FEMALE; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 6; MAJOR CLINICAL STUDY; PAPILLOMA VIRUS; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; SQUAMOUS CELL; URUGUAY; UTERINE CERVIX CANCER;

ADOLESCENT; ADULT; CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; DNA FINGERPRINTING; DNA, VIRAL; FEMALE; GENOTYPE; HUMANS; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PREVALENCE; URUGUAY; YOUNG ADULT;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16;

EID: 84875664841     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23479     Document Type: Article

References (41)

1. Bernard HU, Chan SY, Manos MM, Ong CK, Villa LL, Delius H, Peyton CL, Bauer HM, Wheeler CM. 1994. Identification and assessment of known and novel HPVs by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. J Infect Dis 170:1077-1085.
2. Bosch XF, Manos MM, Muñoz N, Sherman M, Jansen AM, Peto J, Schiffman HM, Moreno V, Kurman R, Shah VK, International Biological Study on Cervical Cancer (IBSCC) Study Group. 1995. Prevalence of human papillomavirus in cervical cancers: A worldwide perspective. J Nat Cancer Inst 87:796-807.
3. Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV. 2002. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55:244-265.
4. Bosch FX, Burchell AN, Schiffman M, Giuliano AR, de Sanjose S, Bruni L, Tortolero-Luna G, Kjaer SK, Muñoz N. 2008. Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia. Vaccine 26:K1-K16.
5. Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, Benbrahim-Tallaa L, Guha N, Freeman C, Galichet L, Cogliano V. 2009. WHO International Agency for Research on Cancer Monograph Working Group. A review of human carcinogenesis-Part B: Biological agents. Lancet Oncol 10:321-322.
6. Castle PE, Solomon D, Schiffman M, Wheeler CM, for the ALTS Group. 2005. Human papillomavirus type 16 infections and two-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalities. J Natl Cancer Inst 97:1066-1071.
7. Comisión honoraria de lucha contra el cáncer (CHLCC), editor. 2007. Programa de Prevención del Cáncer de Cuello Uterino en el Uruguay "Dr Enrique Pouey". Montevideo, Uruguay: Ministerio de Salud Pública (MSP).
8. Ciapponi A, Bardach A, Glujovsky D, Gibbons L, Picconi MA. 2011. Type-specific HPV prevalence in cervical cancer and high-grade lesions in Latin America and the Caribbean: Systematic review and meta-analysis. PLoS ONE 6:e25493.
9. Clifford GM, Rana RK, Franceschi S, Smith JS, Gough G, Pimenta JM. 2005. Human papillomavirus genotype distribution in low-grade cervical lesions: Comparison by geographic region and with cervical cancer. Cancer Epidemiol Biomarkers Prev 14:1157-1164.
10. Correnti M, Medina F, Cavazza ME, Rennola A, Avila M, Fernandes A. 2011. Human papillomavirus (HPV) type distribution in cervical carcinoma, low-grade, and high-grade squamous intraepithelial lesions in Venezuelan women. Gynecol Oncol 121:527-531.
11. de San Josè S, Dìaz M, Castellsaguè X, Clifford G, Bruni L, Muñoz N, Bosch FX. 2007. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: A meta-analysis. Lancet Infect Dis 7:453-459.
12. de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, Tous S, Felix A, Bravo LE, Shin HR, Vallejos CS, de Ruiz PA, Lima MA, Guimera N, Clavero O, Alejo M, Llombart-Bosch A, Cheng-Yang C, Tatti SA, Kasamatsu E, Iljazovic E, Odida M, Prado R, Seoud M, Grce M, Usubutun A, Jain A, Suarez GA, Lombardi LE, Banjo A, Menendez C, Domingo EJ, Velasco J, Nessa A, Chichareon SC, Qiao YL, Lerma E, Garland SM, Sasagawa T, Ferrera A, Hammouda D, Mariani L, Pelayo A, Steiner I, Oliva E, Meijer CJ, Al-Jassar WF, Cruz E, Wright TC, Puras A, Llave CL, Tzardi M, Agorastos T, Garcia-Barriola V, Clavel C, Ordi J, Andujar M, Castellsague X, Sanchez GI, Nowakowski AM, Bornstein J, Munoz N, Bosch FX. 2010. Human papillomavirus genotype attribution in invasive cervical cancer: A retrospective cross-sectional worldwide study. Lancet Oncol 11:1048-1056.
13. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H. 2004. Classification of papillomavirus. Virology 324:17-27.
14. Estrade C, Menoud PA, Nardelli-Haefliger D, Sahli R. 2011. Validation of a low-cost human papillomavirus genotyping assay based on PGMY PCR and reverse blotting hybridization with reusable membranes. J Clin Microbiol 49:3474-3481.
15. Ferreccio C, Prado RB, Luzoro AV, Ampuero SL, Snijders PJ, Meijer CJ, Vaccarella SV, Jara AT, Puschel KI, Robles SC, Herrero R, Franceschi SF, Ojeda JM. 2004. Population-based prevalence and age distribution of human papillomavirus among women in Santiago, Chile. Cancer Epidemiol Biomarkers Prev 13:2271-2276.
16. Goncalves MA, Randi G, Arslan A, Villa LL, Burattini MN, Franceschi S, Donadi EA, Massad E. 2008. HPV type infection in different anogenital sites among HIV-positive Brazilian women. Infect Agent Cancer 3:5.
17. Herrero R, Hildesheim A, Bratti C, Sherman ME, Hutchinson M, Morales J, Balmaceda I, Greenberg MD, Alfaro M, Burk RD, Wacholder S, Plummer M, Schiffman M. 2000. Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst 92:464-474.
18. Herrero R, Castle PE, Schiffman M, Bratti MC, Hildesheim A, Morales J, Alfaro M, Sherman ME, Wacholder S, Chen S, Rodriguez AC, Burk RD. 2005. Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica. J Infect Dis 191:1796-1807.
19. IARC. 1995. IARC Monographs on the evaluation of carcinogenic risks to humans: Human Papillomaviruses. Lyon, France. IARC Sci Publ 64:15-38.
20. Kjaer SK, Breugelmans G, Munk C, Junge J, Watson M, Iftner T. 2008. Population-based prevalence, type- and age-specific distribution of HPV in women before introduction of an HPV-vaccination program in Denmark. Int J Cancer 123:1864-1870.
21. Kjær SK, Frederiksen K, Munk C, Iftner T. 2010. Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: Role of persistence. J Natl Cancer Inst 102:1478-1488.
22. Maniatis T, Fritsch E, Sanbrook J. 1989. Molecular cloning: A laboratory manual New York: Cold Spring Harbor Laboratory Press.
23. Manos MM, Ting Y, Wright DK, Lewis AJ, Broker T, Wolinski SM. 1989. The use of polymerase chain reaction amplification for the detection of genital human papillomavirus. Cancer Cells 7:209-214.
24. Molano M, Posso H, Weiderpass E, van den Brule AJ, Ronderos M, Franceschi S, Meijer CJ, Arslan A, Munoz N. 2002. Prevalence and determinants of HPV infection among Colombian women with normal cytology. Br J Cancer 87:324-333.
25. Munoz N, Kato I, Bosch FX, Eluf-Neto J, De Sanjose S, Ascunce N, Gili M, Izarzugaza I, Viladiu P, Tormo MJ, Moreo P, Gonzalez LC, Tafur L, Walboomers JM, Shah KV. 1996. Risk factors for HPV DNA detection in middle-aged women. Sex Transm Dis 23:504-510.
26. Paesi S, Serafini EP, Barea F, Madi SR, Echeverrigaray S. 2009. High prevalence of human papillomavirus type 58 in patients with cervical pre-malignant lesions in southern Brazil. J Med Virol 81:1270-1275.
27. Parkin DM, Bray F, Ferlay J. 2005. Pisani PGlobal cancer statistics, 2002. CA Cancer J Clin 55:74-108.
28. Quint W, Jenkins D, Molijn A, Struijk L, van de Sandt M, Doorbar J, Mols J, Van Hoof C, Hardt K, Struyf F, Colau B. 2011. One virus one lesion-Individual components of CIN lesions contain a specific HPV type. J Pathol 227:62-71.
29. Rabelo-Santos SH, Zeferino L, Villa LL, Sobrinho JP, Amaral RG, Magalhaes AV. 2003. Human papillomavirus prevalence among women with cervical intraepithelial neoplasia III and invasive cervical cancer from Goiania, Brazil. Mem Inst Oswaldo Cruz 98:181-184.
30. Rodríguez G, Barrios E, Vasallo J. 2005. Características epidemiológicas de una población que accedió al Programa de Prevención del Cáncer de Cuello Uterino en Uruguay. Rev Med Uruguay 21:200-206.
31. Rodríguez AC, Schiffman M, Herrero R, Hildesheim A, Bratti C, Sherman ME, Solomon D, Guillén D, Alfaro M, Morales J, Hutchinson M, Katki H, Cheung L, Wacholder S, Burk RD. 2010. Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: Critical role of duration of infection. J Natl Cancer Inst 102:315-324.
32. Saiki RK, Scharf S, Faloona F, Mullis KB, Horn GT, Erlich HA, Arnheim N. 1985. Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 230:1350-1354.
33. Schmeink CE, Melchers WJ, Siebers AG, Quint WG, Massuger LF, Bekkers RL. 2011. Human papillomavirus persistence in young unscreened women, a prospective cohort study. PLoS ONE 6:e27937.
34. Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, Winer R, Clifford GM. 2007. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: A meta-analysis update. Int J Cancer 121:621-632.
35. Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, Raab S, Sherman M, Wilbur D, Wright T, Jr., Young N. 2002. The 2001 Bethesda System: Terminology for reporting results of cervical cytology. JAMA 287:2114-2119.
36. Tonon SA, Picconi MA, Zinovich JB, Nardari W, Mampaey M, Badano I, Di Lello F, Galuppo JA, Alonio LV, Teyssie AR. 2004. Human papillomavirus cervical infection in Guarani Indians from the rainforest of Misiones, Argentina. Int J Infect Dis 8:13-19.
37. Torroella-Kouri M, Morsberger S, Carrillo A, Mohar A, Meneses A, Ibarra M, Daniel RW, Ghaffari AM, Solorza G, Shah KV. 1998. HPV prevalence among Mexican women with neoplastic and normal cervixes. Gynecol Oncol 70:115-120.
38. Villa L, Franco E. 1998. Epidemiologic correlates of cervical neoplasia and risk of human papillomavirus infection in asymptomatic women in Brazil. J Natl Cancer Inst 81:332-340.
39. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N. 1999. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:12-19.
40. Zuna RE, Wang SS, Rosenthal DL, Jeronimo J, Schiffman M, Solomon D, Group, ALTS. 2005. Determinants of human papillomavirus-negative, low-grade squamous intraepithelial lesions in the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesions triage study (ALTS). Cancer 25:253-62.
41. zur Hausen H. 2002. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2:342-350.